Lymphoproliferative disorder during temozolomide therapy; a representative case of a formidable complication and management challenges

Lymphoproliferative disorder during temozolomide therapy; a representative case of a formidable complication and management challenges

Abstract Background Lymphoproliferative disorder represents a heterogeneous clinicopathological spectrum characterized by uncontrolled proliferation of lymphocytes. Immunodeficiency is a major trigger of its development. While induction of immunodeficiency is a well-known adverse effect of temozolom...

Full description

Bibliographic Details
Main Authors: Daisuke Sato, Hirokazu Takami, Shunsaku Takayanagi, Kazuki Taoka, Mariko Tanaka, Reiko Matsuura, Shota Tanaka, Nobuhito Saito
Format: Article
Language:English
Published: BMC 2023-06-01
Series:BMC Neurology
Subjects:
Lymphoproliferative disorder
Glioma
Temozolomide
Epstein-Barr virus
Online Access:https://doi.org/10.1186/s12883-023-03274-8

Internet

https://doi.org/10.1186/s12883-023-03274-8

Similar Items